Cargando…

Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial

Detalles Bibliográficos
Autores principales: Haas, Naomi B, Stein, Mark N, Tutrone, Ronald, Perini, Rodolfo, Denker, Andrew, Mauro, David, Fong, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645560/
http://dx.doi.org/10.1186/2051-1426-3-S2-P153

Ejemplares similares